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ABSTRACT
Fatty alcohols are excipients that are abundantly used in various pharmaceutical
formulations. The objective of the present study was to evaluate the impact of incorporating
different fatty alcohols on microstructural and formulation characteristics of topical o/w
clotrimazole cream formulation. The formulations containing different fatty alcohols as Kolliwax®
CSA 50 (CSA 50), Kolliwax® CSA 70 (CSA 70), Kolliwax® MA (MA), Kolliwax® CA (CA),
Kolliwax® SA (SA) were prepared by selecting suitable RPM and homogenization time. The M.P.
of API and fatty alcohols were determined using DSC technique. The prepared cream formulations
were evaluated for their phase separation. The various tests like pH, water activity measurement,
work of adhesion measurement, globule size distribution, In vitro permeation study and
rheological study were performed for the characterization of the formulation. All formulations
were made in two batches and were subjected to stability conditions for 3 month at two conditions,
25ᵒC/60% RH and 40ᵒC/75% RH respectively. The initial and 3 month samples were characterized
using tests like, pH, water activity measurement and globule size distribution.
The results for the tests like pH, water activity were found to be comparable in all cream
formulations with different fatty alcohols. In phase separation study, the drug was found to have
partitioned predominantly in the lipid phase with negligible amount present in the aqueous phase
of the cream formulations. The work of adhesion values for all fatty alcohols except SA were
found to be in the same range of values. From the results of globule size distribution, it can be
ii

concluded that CSA50, CSA70, MA and CA were found to form stable o/w cream formulation
with a globule size range 2 to 6µm. SA when used alone in cream formulation, failed to produce a
cream formulation with stable globules. All fatty alcohols containing creams showed yield stress
values ~ 10 Pa, except for the SA sample, which displayed a very low yield stress. The results of
the rheological studies revealed that CSA 50 and CSA 70 form relatively stable microstructure.
As, all products are shear thinning and have comparable yield stress, the rheological characteristics
clearly reflect the microstructural similarities in the formulations. The results of finite and infinite
IVPT studies revealed that the permeation of clotrimazole from all the o/w topical cream
formulations could be enhanced when MA and CA are used in the formulation. The cream products
prepared with different fatty alcohols maintained same characteristics at two storage conditions.
SA was found to be one of the less efficient fatty alcohol in terms of forming a good o/w cream in
the present case.
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CHAPTER I
INTRODUCTION
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Pharmaceutical cream formulations are heterogeneous semisolid systems in which drug is
either dissolved or dispersed in water in oil (w/o) or oil in water (o/w) emulsion. They are widely
used in topical application of the drugs1. An o/w cream besides being non-occlusive in nature also
has emollient properties as it can lead to deposition of lipids and moisturizers on and into the
stratum corneum2.
The basic ingredients used in cream formulations are emollients, viscogens, emulsifying
agents, vehicles, penetration enhancers. It is extremely important to select appropriate combination
of these ingredients to formulate a stable topical cream formulation. Fatty alcohols are excipients
that are abundantly used in various pharmaceutical formulations. Chemically, fatty alcohols are
aliphatic hydrocarbons with a hydroxyl group at the terminal position and are derived from either
plants or animal oils and fats.
Inactive Ingredient database of FDA has 44 listings of approved NDA topical formulations
with different fatty alcohols like myristyl alcohol, cetyl alcohol, stearyl alcohol or cetostearyl
alcohol3. There are also approved generic topical semi-solid products that contain different fatty
alcohols which can be identified at US National institute of Health Daily Med database4
Fatty alcohols play multiple roles leading to development of topical products of desired
efficacy, safety and stability. Fatty alcohols are used in creams to impart the desired sensorial and
functional characteristics to the formulation. They can influence texture characteristics and
improve the rheological properties of topical products. They act as solubility enhancers for some
of the poorly soluble APIs. They can also play the role of permeation enhancer by improving the
drug penetration into as well as across the skin.
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Fatty alcohols were found to influence the rate of metamorphosis of the cream product after
application on the skin. The rate of drying and metamorphosis of the product on the skin surface
determines the extent of dermal absorption of therapeutic agents. The fatty alcohols also found to
influence the spreadability, spreading area, skin cooling and work of adhesion properties of the
topical products. Incorporation of fatty alcohols as a part of any pharmaceutical or cosmetic cream
formulation helps the formulator to impart the desired characteristics to the product by the way of
changing the fatty alcohol type and ratio. The type of vehicle used in the topical formulation can
also play an important role in permeation of drug. The solubility of drug in different components
of formulation and in stratum corneum can influence partitioning of drug from the dosage form5,6.
Clotrimazole is an azole derivative having a broad-spectrum antifungal activity. The drug
is known to act by binding to cytochrome P 450 enzymes, which are required for demethylation
of lanosterol to ergosterol. Ergosterol concentrations get reduced leading to damaged and leakage
in the cell membranes leading to the prevention of fungal growth7. The chemical structure of
clotrimazole is as shown in Figure 18.

Figure 1: Chemical structure of clotrimazole
3

It is used to treat skin infections like athlete’s foot, jock itch, ringworm. It also can be used
to treat a skin condition called as pityriasis and for fungal infection that causes a lightening or
darkening of the skin in the area of the neck, chest, arms or legs9.
Clotrimazole is commonly formulated in the form of topical cream and most of these
formulations are available over the counter. Few examples of FDA approved products containing
clotrimazole as an active ingredient are described in Table 1.

Table 1: FDA approved products containing clotrimazole

Product Name

Strength

Dosage form/route

Company

MYCELEX(10)

1%

Solution; topical

Bayer Healthcare

MYCELEX-7(11)

1%

Cream; vaginal

Bayer Healthcare LLC

CLOTRIMAZOLE(12)

1%

Cream; vaginal

Taro

There is a need of studying the influence of commercially available pharmacopoeial grade
fatty alcohols on a drug-containing cream modeled after commercially available clotrimazole
formulations as a majority of the studies reported have been based on simple model systems with
water, emulsifier and fatty alcohols.
Hence, the present study focused on evaluating influence of fatty alcohols on the
characteristics and performance of the topical o/w cream formulation containing clotrimazole.
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CHAPTER II
OBJECTIVE OF THE STUDY
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The objective of the present study was to evaluate the influence of fatty alcohols on
formulation characteristics and dermal delivery of clotrimazole. Clotrimazole containing topical
O/W cream formulations with different fatty alcohols were prepared and characterized.
Research Strategy: The formulations containing different fatty alcohols

such as

Kolliwax®CSA 50( CSA 50), Kolliwax® CSA 70 (CSA 70), Kolliwax®MA (MA), Kolliwax®
CA(CA) , Kolliwax® SA (SA) were prepared at set homogenization protocol. The API and fatty
alcohols were characterized by determination of M.P. by DSC. The various tests like pH, water
activity measurement, work of adhesion measurement, globule size distribution and rheological
study were performed for the characterization of the formulation.
In vitro permeation studies at finite and infinite dose conditions were performed across porcine
epidermis model using Franz diffusion cells. All formulations were made in two batches and were
subjected to stability conditions for 3 months. Formulations were kept at two conditions, 25ᵒC/60%
RH and 40ᵒC/75% RH respectively. The initial and 3 month samples were characterized for pH,
water activity measurement and globule size distribution.
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CHAPTER III
MATERIALS AND METHODS
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Materials
Clotrimazole (≥ 98%) was gifted by YRROW CHEM PRODUCTS, Mumbai.
Kolliwax®CSA 50 (cetostearyl alcohol 50), Kolliwax® CSA 70 (cetostearyl alcohol 70),
Kolliwax®MA (myristyl alcohol), Kolliwax® CA (cetyl alcohol), Kolliwax® SA (stearyl alcohol),
Kollisolv™ PG (propylene glycol), Kollicream™ OD (octyldodecanol) and Kolliphor™ CS 20
(macrogol cetostearyl ether 20) were gifted by BASF. Euxyl 320 and Nile Red were purchased
from Sigma Aldrich. High Performance Liquid Chromatography (HPLC)-grade solvents like
methanol, ethanol were purchased from Fisher Chemicals, USA. Porcine skin was obtained from
Pontotoc Slaughterhouse, Pontotoc, MS, USA. The wide mouth containers (10 oz.) were purchased
from U Line suppliers.
Methods

Table 2: Preparation of clotrimazole containing o/w formulations
Ingredient

Description

Purpose

w/w%

Kollisolv™ PG

Propylene glycol

Solvent

8

Fatty alcohol#

Fatty alcohol

Viscogen

9

Kollicream™ OD

Octyldodecanol

Emollient

6

Kolliphor™ CS 20

Macrogol cetostearyl ether 20

Emulsifier

1

Active Ingredient

Clotrimazole (clz)

API

1

Water

-

Solvent

75

Euxyl 320

Phenoxyethanol

Preservative

q.s.

Dye

0.0005

Nile Red
8

Table 3: The list of fatty alcohols with their brand names
Fatty alcohol#
Brand Name

Chemical Name

Kolliwax® CSA 50
Kolliwax® CSA 70
Kolliwax® MA
Kolliwax® CA
Kolliwax® SA

Cetostearyl alcohol 50
Cetostearyl alcohol 70
Myristyl alcohol
Cetyl alcohol
Stearyl alcohol

The formula for the cream preparation was used as mentioned in Table 2 and fatty alcohols
used in the study were as shown in Table 3. Aqueous and lipid phase were heated separately at
60ᵒC. Lipid phase was added slowly with the constant speed to the aqueous phase. Both the phases
were homogenized for 30 minutes at 3000 RPM in Silverson Homogenizer L5M-A (Silverson
Machines INC, USA). The constant temperature was maintained during the transfer and
homogenization of both the phases. Propylene glycol along with the Clotrimazole API was added
at the end of the 30 minutes followed by the cooling program. Cooling program- 60ᵒC to 25ᵒC in
20 minutes was given using VWR cooling/heating probe and throughout the cooling, speed of
3000 RPM in Silverson Homogenizer L5M-A was maintained. These batches were made in the
quantity of 300 gm. The brief steps involved in the preparation of topical O/W cream were as
shown in Figure 2.
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Aqueous
Phase

Oil Phase

60ᵒC
Homogenization for
30 minutes at 3000
RPM

Cooling Program: 60ᵒC to
25ᵒC in 20 minutes at 3000
RPM

Figure 2: Steps in preparation of topical o/w cream
HPLC Analysis
An isocratic HPLC method was developed for the quantification of clotrimazole3. The
experiment was performed using a Waters HPLC system (Water 600 Controller, USA) equipped
with a 600-pump unit, a 717 plus auto sampler with an injection valve with a sample loop of 50
µl, and a 2487 dual absorbance UV detector. The 10mmM solution of dibasic potassium phosphate
was made and was used with acetonitrile. The mobile phase had acetonitrile and buffer (3:1 v/v)
and was delivered at a flow rate of 1 ml/min. Then, 20 µl of the injection was eluted in column.
The calibration curve was prepared using different concentrations of API in the range of 1µg to
10ng and methanol: water (90:10 v/v) was used as a solvent. LOD, LOQ were determined.
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Measurement of M.P.using DSC
The M.P. of all five fatty alcohols were determined using DSC 25 (TA Instruments
Delaver, USA) technique. The M.P. of the API was also determined. Around 7 mg of powdered
sample was placed in Tzero Hermetic Pan and was sealed with Tzero lid. The pan was placed in
the sample chamber along with the reference pan and analysis was done by using Ramp method
with the rate of 10ᵒC/min.
pH measurement
The pH of the creams was measured by using Mettler Toledo Inc. USA pH meter. The
probes used in the study are METTLER TOLEDO InLab®Science Pro, 0….12.0, 0….100ᵒ C and
METTLER TOLEDO InLab®Micro, 0….12.0, 0….100ᵒC. The pH meter was calibrated using
standard buffers with the known pH of 4.0, 7.0 and 10.0 respectively. The pH of each cream
formulation was measured thrice. In between every individual measurement, the pH using buffer
standard of pH 4.0 and using buffer standard of pH 10.0 after the next measurement was noted.
Phase separation study
The study was performed by weighing 1 gm of each sample in eppendorf. The samples
were subjected to centrifugation at 50,000 RPM in Beckman Coulter centrifugation instrument
(Beckman Coulter Inc USA). All formulations were centrifuged for 8 hrs. The separated oil phase
and aqueous phase were weighed separately. The 2mg of oil phase was diluted to 50 ml with
methanol and aqueous phase was diluted by adding 2 ml of methanol. The samples were subjected
to HPLC analysis. The distribution of drug in both the phases was evaluated.
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Water Activity measurement
The water activity of all cream formulations was measured by using AQUALAB water
activity meter series 3 and 3TE (Series 3E, USA) as shown in Figure 3. All measurements were
performed at 32ᵒ C. The instrument was calibrated using DI water and the water activity of each
formulation was recorded. The DI water was taken in sampling cup and kept in the sampling
chamber of the instrument. The values were noted thrice and the instrument was found to be
suitable if the water activity for DI water comes equal to 1.00. The samples were analyzed in
triplicate and the average of the values was reported.

Figure 3: Water activity meter (Series 3E, USA)

Work of Adhesion
The test was performed using TA-XT2i Texture Analyser (Texture Technologies Corp) as
shown in Figure 4. TA3 1" dia cylinder,w.radius,acrylic probe as shown in Figure 5. was used for
the measurement of work of adhesion of the samples10,11.
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Figure 4: Texture Analyzer (TAXT2i, Texture Tech. Corp., Scarsdale, NY)

Globule size measurement
The globule size of the cream formulation was measured by using Axio Cam HR3 (Carl
Zeiss Microscopy, Germany) bright field microscopy at the magnification scale of 50 x 2.5. The
thin smear of the cream was prepared with the help of coverslip on the glass slide and observed
immediately under the microscope. For each cream, the mean diameter of randomly distributed
100 globules was measured using the Zen Lite software. The globule size measurement was done
by calculating d10, d50 and d90 values for each cream.
Rheological Study
The rheology of all samples were studied using TA Instruments HR2 Rheometer (TA
Instruments, New Castle, DE) at 32 °C with 20 mm parallel plate with 600 grit sandpaper and
solvent trap.
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In vitro Drug Permeation Study
A fresh porcine skin was brought from a local slaughterhouse. The abdominal skin regions
were taken and shaved using an electric shaver. The hairless skin was cut into small rectangular
pieces. Then, the pieces were covered with aluminium foil and immersed in a water bath
maintained at 60 ºC for 2 min. After 2 min, the aluminium foil was removed and the epidermis
was carefully mounted by hand on clean glass slides. Then, the epidermis was kept for 12 h until
it was completely dried and then was stored in a refrigerator at 5 ºC for future use. The in vitro
skin permeation study was performed using Franz diffusion cells with an effective diffusion area
of 0.64 cm2. A hairless porcine epidermis was sandwiched between the donor and receiver
medium with the SC side facing the donor compartment. The receiver compartment (5ml)/were
filled with an ethanol/PBS solution (30:70) as a reservoir solution12 and was maintained at 37 °C.
The dose for infinite dose study was 300 mg/cm2, and that for finite dose study was 10 mg
/cm2 respectively. The infinite dose study was carried out as the dose is several fold higher than
the clinically relevant dose and at such high dose, the influence of drying and metamorphosis of
the product would be negligible. The steady state flux is a good parameter to understand the
formulation and API related properties in relevance to drug delivery. The finite dose studies would
be close to clinically relevant dose and it would reveal the way the formulation would behave
and perform in real life situation.
During the IVPT studies, the entire receiver compartment was fluid was withdrawn at the
time points of 0,2,4,8 and 12h and replaced by equal quantities of fresh medium. The amount of
clotrimazole in these samples was quantified and determined using HPLC. The cumulative amount
of drug permeated at different time points was plotted and steady state flux was calculated from
14

the slope of the line in infinite dose study. Whereas in finite dose study, the midpoint average flux
was calculated and plotted to determine the maximum flux (Jmax) and AUC0-t
The porcine epidermis was selected as the stratum corneum has been reported to be closely
resemble in terms of structure and composition with human stratum corneum13. The porcine skin
is found to have a comparable drug permeability with human skin14. Porcine skin has shown
histological as well as biochemical similarities with human skin14,15,16,17.

Stability Studies
The quantity of 20 gm from each drug-containing batch was kept for stability studies. The
samples were kept at conditions of 25ᵒC/60% RH and 40ᵒC/75% RH for 3 months in stability
chambers. The samples were withdrawn and analysed for initial and 3 months.

Following tests were performed at each time interval,
1.

Microscopy i.e. globule size measurement

2.

pH determination

3.

Water activity measurement

15

CHAPTER IV
RESULTS AND DISCUSSION
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HPLC analysis

Table 4: HPLC results for different clotrimazole standard preparations
Concentration
(μg/ml)
1
0.75
0.5
0.25
0.1
0.05
0.025
0.01

Area
472432
278827
255131
133342
56464
25702
18783
11072

500000
y = 450140x
R² = 0.9712

Area

400000
300000
200000
100000
0
0

0.2

0.4

0.6

0.8

Concentration (µg/ml)

Figure 5: Clotrimazole standard calibration curve
17

1

From Table 4, the LOQ was found to be at 10 ng. The concentration lower than 10 ng was
detectable but was not being able to get quantified by the HPLC method. As shown in Figure 5,
the calibration curve was plotted and the value of R2 was found to be 0.97 which indicated that
regression line correctly fits with the data.
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Physicochemical properties of fatty alcohols
M.P. for different fatty alcohols were found to be as shown in Figure 6. Different
physicochemical properties of fatty alcohols were as shown in Table 4.

Figure 6: M.P. determination of fatty alcohols using DSC technique
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Table 5: Physicochemical properties of fatty alcohols

CSA 50

CSA 70

CA

SA

MA

M.P

51.97ᵒC

54.3ᵒC

49.3°C

59.5°C

38°C

C-chain length (21-24)

16-18

16-18

C16

C18

C14

512.94

512.94

242.43

270.48

214.39

g/mol

g/mol

g/mol

g/mol

g/mol

7.53

7.25

6.83

8.22

6.03

Avg. Mol. Wt.(21-24)
log P (22-24)

Measurement of pH of topical o/w cream formulations

Table 6: pH values for topical o/w cream formulation

Name
CSA 50
CSA 70
CA
SA
MA

pH
5.75 ± 0.05
5.89 ± 0.02
5.79 ± 0.02
5.79 ± 0.01
5.79 ± 0.01
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Clotrimazole is weakly basic in nature18. As per the pH/partition theory, the unionized drug
has more ability to permeate compared to the ionized form of the drug. We have earlier found that
the pH of the topical products could change post application on the skin to homeostasis with the
pH of the skin, pH 5. As in this case, the initial pH of the formulation is close to 5, there is less
concern about any change in the ionized/unionized drug ratio due to meager changes in the pH of
the formulation.

21

Phase distribution study
Table 7: Phase separation study for topical o/w cream formulation

CSA
50

CSA
70

CA

SA

MA

Clotrimazole in

Total

Clotrimazole in

each phase/gm of

amount of

each phase(μg)

sample(mg)

drug (mg)

Oil Layer

8577.60

8.58

Intermediate
waxy Layer

599.93

0.60

Aqueous Layer

8.71

0.01

waxy Oil Layer

9040.232

9.04

Intermediate
waxy Layer

22.09

0.22

Aqueous Layer

3.14

0.00

Oil Layer

10852.86

10.85

Intermediate
waxy Layer

348.04

0.35

Aqueous Layer

4.50

0.00

Oil Layer

10775.13

10.78

Intermediate
waxy Layer

204.60

0.20

Aqueous Layer

1.29

0.00

Oil Layer

11246.40

11.25

Intermediate
waxy Layer

102.33

0.10

Aqueous Layer

0.70

0.00
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9.19

9.27

11.21

10.98

11.35

In case of all the creams, the drug was found to have partitioned predominantly in the
lipid phase with negligible amount present in the aqueous phase as seen in Table 7.
Water Activity measurement

Table 8: Water activity measurement of clotrimazole containing o/w creams with different
fatty alcohol

Name

Water Activity (aw)

CSA 50

0.97 ± 0.00

CSA 70

0.97 ± 0.00

CA

0.96 ± 0.00

SA

0.97 ± 0.00

MA

0.99 ± 0.01

Water activity values give idea about the microbial stability of the formulation19. Water
activity is simply defined as the ratio of the vapor pressure of pure water (100% equilibrium
relative humidity) over the vapor pressure of the sample. Water activity can have influence on the
drug permeation from the formulation as it was found that water activity gradient between outer
layers of skin and formulation vehicle can change the amount of water loss from skin19. Being o/w
cream in nature, the values were found to be higher as shown in Table 8. The water activity values
were found comparable for all fatty alcohols.
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Work of adhesion

Table 9: Work of adhesion measurement of Clotrimazole containing o/w creams with
different fatty alcohols
Work of Adhesion
(g.sec)
27.48 ± 0.68
20.50 ± 0.04
26.70 ± 0.69
17.04 ± 0.37
25.75 ± 0.62

Name
CSA 50
CSA 70
CA
SA
MA

As shown in Table 9, work of adhesion values for all fatty alcohols except SA were found
to be in the same range of values. Work of adhesion could be the sensitive tool for determination
of parameters like spreadability of the cream formulation.
The Young- Dupre equation, gives an idea about the surface tensions of liquid, soild and
surface tension at the interface of solid-liquid along with the contact angle between them20,
Wab = ᵞ1(1+ cos)
Wab = work of adhesion between two phases, ᵞ = surface tension and cos = contact angle
The work of adhesion is an interfacial phenomenon as it helps in determining force required
to separate solid surface from the liquid surface.
From the results mentioned in Table 9, the SA has low work adhesion indicating the more
spreadability of the formulation.
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Globule size measurement

Table 10: Globule size measurement of clotrimazole containing o/w creams with different

Name

d10 (µm)

d50 (µm)

d90 (µm)

CSA 50
CSA 70
CA
SA
MA

2.61 ± 0.00
2.50 ± 0.14
2.55 ± 0.07
N.A.
2.05 ± 0.07

4.05 ± 0.07
3.90 ± 0.42
3.75 ± 0.35
N.A.
3.05 ± 0.07

5.45 ± 0.21
5.20 ± 0.57
4.90 ± 0.71
N.A.
3.80 ± 0.10

14
12
10
8
6
4
2
0

0
0.75
1
1.25
1.5
1.75
2
2.25
2.5
2.75
3
3.25
3.5
3.75
4
4.25
4.5
4.75
5
5.25
5.5
5.75
6
6.25

Number of Globules

fatty alcoholsITIAL

Globule Size (µm)

7 (a). CSA 50
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0
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1
1.25
1.5
1.75
2
2.25
2.5
2.75
3
3.25
3.5
3.75
4
4.25
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5
5.25
5.5
5.75
6
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Number of Globules
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8

6

4

2

0
Globule Size (µm)

7 (b). CSA 70
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Number of Globules

20

Globule Size (µm)

7(e). MA

Figure 7: Photomicrographs and globule size distribution for clotrimazole creams
containing different fatty alcohols
As shown in Table 10 and Figure 7, the globule size distribution of creams containing CSA
50 was found to have d10, d50 and d90 as 2.6 ± 0.01 , 4.0 ± 0.06 and 5.4 ± 0.23µm respectively.
In case of CSA 70, CA and MA the globule size values did not differ significantly from that of
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CSA 50. However in cream containing SA, emulsification was not complete and globules were
found to be irregular and larger in size.
From the results of globule size distribution, it can be concluded that CSA50, CSA70, MA
and CA were found to form stable o/w cream formulation with a globule size range 2 to 6 µm. SA
when used alone in cream formulation, failed to produce a cream formulation with stable globules.

Rheological study
In semisolid emulsions, surfactants and fatty alcohol contribute towards formation of
viscoelastic gel network which helps in stabilizing the oil droplets into the water phase. Type of
surfactant whether ionic or nonionic along with its homologous composition affect the structure
of the gel network. This phenomenon results in giving particular appearance and rheological
stability to the formulation21,22.The surfactant emulsifiers reduce the surface tension which helps
in easy breakdown of droplets during the emulsification process. This process facilitates
formation of viscoelastic gel network. Higher mixed emulsifier concentrations lead to linkage of
crystalline and gel phases forming a semisolid cream23. The mixtures which form lamellar phases
in the bulk can form strong viscoelastic films at the interface23,24. Fatty alcohols have tendency of
swelling in the presence of nonionic surfactant. Surfactant gets interpositioned between the
alcohol molecules and alpha crystals of alcohol resulting in swelling because of the hydration
POE chains of the surfactant20,25,21.
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Figure 8: Yield Stress study for clotrimazole creams containing different fatty alcohol
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Figure 9: Stress vs shear rate study for clotrimazole containing o/w creams with different
fatty alcohols

Table 11: Viscosities at different shear rates of clotrimazole containing o/w creams with
different fatty alcohols
0.01
(1/s)

At the shear
rate: 20 s-1

Yield
Stress (Pa)

CSA50

2397

N/A

16

CSA70

1838

N/A

13

CA
SA
MA

3137
1132
1276

3.6
1.3
1.5

9
1
12
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Previous studies have reported reduction in consistency of formulations containing cetyl
alcohol and stearyl alcohol during the storage period21. The yield stress values as shown in Figure
8 and Table 11. All fatty alcohols containing creams showed yield stress values ~10 Pa, except for
the SA sample, which displayed a very low yield stress. When stress vs shear rate was plotted,
there was increasing shear rate (forward) with decrease in viscocity for all samples, indicating that
the samples were shear thinning as seen in Figure 9. The hysteresis has been found to be highest
in SA sample. CSA 50 and CSA 70 samples did not display any significant hysteresis indicating
that their ability to impart robustness to the products. Shear thinning behaviour of cream
formulation gives an idea about the spreadability of the formulation and it is an indicative of
stability of the formulation26.
The results of the rheological studies revealed that CSA 50 and CSA 70 form relatively
stable microstructure. This could be attributed to the fact that cetostearyl alcohol can stabilize the
emulsion due to lamellar gel network. Also, cetostearyl alcohol provides stability to the
formulation due to chain-length mismatch which is not found in the pure cetyl alcohol nor stearyl
alcohol. Chain-length mismatch also reduces the melting enthalpy in comparison to pure fatty
alcohols27. As, all products were found to be shear thinning and have comparable yield stress, the
rheological characteristics clearly reflect the microstructural similarities in the formulations.
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Cumulative amount permeated
(µg/cm2)

In vitro Drug permeation study using infinite dose study for o/w cream formulations

0.9

CSA 50

0.6

CSA70
CA

SA

0.3

MA
0.0
0

2

4

6

8

10

12

Time(h)

Figure 10: IVPT profile of clotrimazole at Infinite Dose from clotrimazole containing O/W cream
[n=2 donors (3-6 replicate each donor ±SEM)]
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Table 12: Clotrimazole O/W cream infinite dose IVPT study Steady state flux values and
physicochemical properties of fatty alcohols

Fatty alcohol

Steady state flux
(µg/cm2/h)

M.P.(ᵒC)

CSA 50
CSA 70
CA
SA
MA

0.028 ± 0.011
0.015 ± 0.004
0.041 ± 0.021
0.015 ± 0.004
0.064 ± 0.028

51.97
54.3
49.3
59.5
38

0.1
0.09

steady state flux(µg/cm2/h)

0.08
0.07
0.06
0.05
0.04
0.03
0.02
0.01
0
30

35

40

45
50
Melting Point(ᵒC)

55

60

65

Figure 11: The relationship between steady state flux and M.P. of each fatty alcohol
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Fatty alcohols have shown an ability to act as effective permeation enhancers of drugs in
many formulations14. The steady state flux of drug from o/w creams containing different fatty
alcohols was determined from the cumulative release versus flux data as shown in Table 12 and
Figure 10. The results clearly show that the type of fatty alcohol incorporated has a significant
impact on the drug permeation from o/w creams. Creams incorporated with MA and CA resulted
in higher permeation of clotrimazole than those prepared with CSA50.
In the present work, it was presumed that the drug permeation could depend on the ability of fatty
alcohols to interact with stratum corneum lipids by disrupting the densely packed lipids in the
extracellular spaces of the stratum corneum14.
In 1990, Flynn proposed that physicochemical properties of chemicals can influence their
permeation through skin28. Potts and Guy established quantitative correlation between
physicochemical properties such as molecular weight, log P of molecule and flux across the skin29.

log kp = - 2.7 + 0.71* log P- 0.0061*MW
kp= permeability coefficient, log P = partition coefficient, MW = molecular weight
Barratt30 extended the Potts and Guy equation by using melting point and molecular volume
to predict the permeability of the molecules. He performed multiple regression analysis of log PC
against log P(partition coefficient),molecular volume and melting point.
log PC = - 0.00484*MV + 0.71* log P- 0.00515*MP-2.655
PC= permeability coefficient, log P = partition coefficient, MV= molecular volume,
35

MP =melting point
Hence, the same concept was used to establish the correlation between the steady state flux
and melting point of fatty alcohols in the present study. There was an inverse correlation as shown
in Figure 11, observed between the steady state flux of drug (which in turn shows the extent of
modulation of skin permeability by the fatty alcohol) with melting point of the fatty alcohol
incorporated in the cream product. This explains the reason why the permeation of clotrimazole in
cream with MA, was found to have more drug permeation than creams having fatty alcohols with
higher melting point.

In vitro Drug permeation study using finite dose study for o/w cream formulations
The finite dose permeation flux versus time profile followed a typical up and down curve
in all the cases as shown in Figure 12. The J (max) values from CSA 50 and 70 were comparable
and was lesser than other fatty alcohols used in neat form as seen in Figure 13 and Table 13.
Myristyl alcohol and cetyl alcohol containing formulation resulted in a significantly higher Jmax
values than the other fatty alcohols. The AUC for the formulations containing MA and CA was
found to be higher compared to other fatty alcohols as shown in Table 14 and Figure 14. Although
Tmax was different, the Jmax was comparable between MA and CA.
The results of finite and infinite studies revealed that the permeation of clotrimazole from
all the o/w topical cream formulations could be enhanced when MA and CA are used in the
formulation.
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Avg. Flux (µg/cm 2/h)

0.8
CSA 50

0.6

CSA70
CA

0.4

SA
0.2

MA

0.0

0

2

4

6
Time (hr)

8

10

12

Figure 12: IVPT profile of clotrimazole at finite Dose from clotrimazole containing O/W
cream [n=2 donors (3-6 replicate each donor ±SEM)

Table 13: IVPT finite dose study Jmax and standard error of means for clotrimazole
creams containing different fatty alcohols

Fatty alcohol

J (max) (µg/cm2/h) ± SEM

CSA 50
CSA 70
CA
SA
MA

0.102 ± 0.070
0.247 ± 0.110
0.663 ± 0.351
0.166 ± 0.059
0.635 ± 0.279
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Jmax (µg/cm2/h)

1
0.8
0.6
0.4
0.2
0
CSA 50

CSA 70

CA

SA

MA

Figure 13: IVPT profile of clotrimazole at finite Dose study J max for clotrimazole
containing o/w cream

Table 14: IVPT finite dose study Area under the curve and standard error of means for
clotrimazole creams containing different fatty alcohols
Fatty alcohol

AUC (µg/cm2)

CSA 50

0.184 ± 0.132

CSA 70

0.618 ± 0.443

CA

1.835 ± 1.122

SA

0.321 ± 0.176

MA

1.211 ± 0.602
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AUC0-t (µg/cm2)

2

1.5

1

0.5

0
CSA 50

CSA 70

CA

SA

MA

Figure 14: The Area under the curve from IVPT profile of clotrimazole at finite dose for
clotrimazole containing o/w cream
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Stability Study
Table 15: Results for initial samples of clotrimazole containing o/w creams with different
fatty alcohols

INITIAL
CSA 50

CSA 70

CA

SA

MA

Avg.

Avg.

Avg.

Avg.

Avg.

5.75 ± 0.05

5.89 ± 0.02

5.79 ± 0.02

5.79 ± 0.01

5.79 ± 0.01

0.97 ± 0.00

0.97 ± 0.00

0.96 ± 0.00

0.97 ± 0.00

0.998 ± 0.00

d10 (µm)

2.61 ± 0.00

2.50± 0.14

2.55 ± 0.07

N.A

2 .05 ± 0.07

d50 (µm)

4.05 ± 0.07

3.90 ± 0.42

3.75 ± 0.35

N.A

3.05 ± 0.07

d90 (µm)

5.45 ± 0.21

5.20± 0.57

4.90 ± 0.71

N.A.

3.80 ± 0.10

pH
Water
Activity (aw)

Table 16: Stability study results for 3-month samples at 25ᵒC/60% RH of clotrimazole
containing o/w creams with different fatty alcohols
3M (25ᵒC/65% RH)
CSA 50

CSA 70

CA

SA

MA

Avg.

Avg.

Avg.

Avg.

Avg.

7.30 ± 0.05

7.23 ± 0.02

7.11 ± 0.01

7.30 ± 0.01

6.87 ± 0.01

0.98 ± 0.00

0.97 ± 0.00

0.99 ± 0.00

0.98 ± 0.00

0.98 ± 0.00

d10 (µm)

2.60 ± 0.14

2.45 ± 0.21

1.90 ± 0.28

N.A

2 .30 ± 0.0

d50 (µm)

4.00 ± 0.28

3.80 ± 0.28

3.50 ± 0.00

N.A

3.30 ± 0.14

d90 (µm)

5.45 ± 0.35

5.05± 0.21

5.10 ± 0.14

N.A.

4.25 ± 0.05

pH
Water Activity
(aw)
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Table 17: Stability study results for 3-month samples at 40ᵒC/75% RH of clotrimazole
containing O/W creams with different fatty alcohols
3M (40ᵒC/75% RH)
CSA 50

CSA 70

CA

SA

MA

Avg.

Avg.

Avg.

Avg.

Avg.

7.15 ± 0.01

6.65 ± 0.01

6.96 ± 0.01

6.89 ± 0.01

6.32 ± 0.01

0.97 ± 0.00

0.98 ± 0.00

0.98 ± 0.00

0.98 ± 0.00

0.99 ± 0.00

d10 (µm)

2.25 ± 0.21

2.25 ± 0.21

1.75 ± 0.49

N.A

2 .15 ± 0.07

d50 (µm)

3.85 ± 0.21

3.60 ± 0.00

2.80 ± 0.85

N.A

3.20 ± 0.14

d90 (µm)

5.25 ± 0.21

5.05 ± 0.35

4.25 ± 1.20

N.A.

4.35 ± 0.07

pH
Water Activity
(aw)
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B1

B2
Initial

Figure 15: Photomicrograph for initial samples of clotrimazole containing o/w creams with
CSA 50

B1

B2
3 Month
25°C/60%RH

Figure 16: Photomicrograph for 3M 25°C/60%RH samples for clotrimazole containing
O/W creams with CSA 50
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B1

3 Month
40°C/75%RH

B2

Figure 17: Photomicrograph for 3M 40°C/75%RH samples for clotrimazole containing o/w
creams with CSA 50

B1

B2
Initial

Figure 18: Photomicrograph for initial samples for clotrimazole containing O/W creams
with CSA 70
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B1

3 Month
25°C/60%RH

B2

Figure 19: Photomicrograph for 3M 25°C/60%RH samples for clotrimazole containing o/w
creams with CSA 70

B1

B2
3 Month
40°C/75%RH

Figure 20: Photomicrograph for 3M 40°C/75%RH samples for clotrimazole containing o/w
creams with CSA 70
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B1

B2
Initial

Figure 21: Photomicrograph for initial samples for clotrimazole containing o/w creams
with CA

B1

3 Month
25°C/60%RH

B2

Figure 22: Photomicrograph for 3M 25°C/60%RH samples for clotrimazole containing o/w
creams with CA
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B1

B2
3 Month
40°C/75%RH

Figure 23: Photomicrograph for 3M 40°C/75%RH samples for clotrimazole containing
O/W creams with CA

B1

B2
Initial

Figure 24: Photomicrograph for initial samples for clotrimazole containing o/w creams
with SA
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B1

B2
3 Month
25°C/60%RH

Figure 25: Photomicrograph for 3M 25°C/60%RH samples for clotrimazole containing o/w
creams with SA

B1

B2
3 Month
40°C/75%RH

Figure 26: Photomicrograph for 3M 40°C/75%RH samples for clotrimazole containing o/w
creams with SA
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B1

B2
Initial

Figure 27: Photomicrograph for initial samples for clotrimazole containing o/w creams
with MA

B1

3 Month
25°C/60%RH

B2

Figure 28: Photomicrograph for 3M 25°C/60%RH samples for clotrimazole containing o/w
creams with MA
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Figure 29: Photomicrograph for 3M 40°C/75%RH samples for clotrimazole containing o/w
creams with MA

As shown in Table 15-17, the products prior to storage had pH values in the range of 5.75
± 0.05 to 5.89 ± 0.02 and it did change significantly at both the storage conditions. This change
could be because of the change in the partitioning of fatty acids from aqueous phase to lipid phase
leading to increase in the pH of the formulation.
The water activity results were not altered and were found to be in the same range of 0.97
± 0.00 to 0.99 ± 0.00. The d10, d50 and d90 values for initial samples were found to be in the same
range as that of 3 month old samples and the globule size distribution was also found to be closer
to initial values for all the cream products except for cream product containing SA which showed
irregular shaped globules leading to poor globule size distribution. The results are expressed as
mean ± SEM in all cases and as mean ± SD in case of globule size distribution. The microscopical
images for all samples at both the storage conditions are as shown in Figure 15-30.

49

The cream products prepared with different fatty alcohols maintain same characteristics at
two storage conditions. SA was found to be one of the less efficient fatty alcohol in terms of
forming a good o/w cream in the present case.
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CHAPTER V
CONCLUSION
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The pH, water activity and globule size were found to be in the same range for cream
formulations containing different fatty alcohols. CSA 50 and CSA 70 containing creams were
found to have stable microstructure during rheological evaluations. Cream containing SA did not
form a proper emulsion as evident from microscopic study, texture analysis and rheology. In
infinite and finite dose IVPT studies, MA containing cream showed higher transdermal
permeation of clotrimazole. A good correlation was found between the steady state flux of
clotrimazole and melting point of fatty alcohols. The cream formulations with different fatty
alcohols showed stable results of water activity and globule size at both the storage conditions.
However, pH values changed significantly during stability study. Hence, it was concluded that
fatty alcohols can play different roles like permeation enhancer, stabilizing agent, viscogen in
formulation. The formulator can select either the single or combination of fatty alcohols for
achieving desired characteristics in the formulation.
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